4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-002751
EVP, COO, Head of Commercial sold 538 shares at $23.05 ($12,401)
- EVP, COO, Head of Commercial acquired 1,286 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, Head of Commercial | 2022-01-06 | Option exercise | +1,286 | 2,326 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2022-01-06 | Sale | −538 | $23.05 | $12,401 | 1,788 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, Head of Commercial | 2022-01-06 | Option exercise · Restricted Stock Units | −1,286 | 2,573 | D | ||
| Open-market sales · 538 sh · avg $23.05 · $12,401 | |||||||
Loading xslF345X03/doc4.xml…